Fibrocystic changes of the breast are mostly a benign breast disease. However, this may depend on the subtype and degree of cellular atypia.
Fibrocystic changes most commonly occur in premenopausal women 20-50 years old. Though the etiology is generally unknown, it is thought that excess estrogen coupled with a lack of progesterone could lead to fibrocystic changes.
A presenting symptom can be bilateral, multifocal breast pain with tender or nontender breast lumps/nodules. There can also be clear or milky nipple discharge.
First line diagnostic procedures include ultrasound and mammography. Ultrasound findings may be normal but otherwise would show thick parenchyma consistent with the fibrous changes and the presence of multifocal cystic lesions (anechoic fluid). A fine needle aspiration (FNA) can be performed to evaluate the tissue further.
Mammograms of patients with fibrocystic changes could show round masses with clear borders and/or calcifications. If there is the presence of a cystic lesion and/or the patient is symptomatic, then a fine needle aspiration (FNA) can be performed.
A biopsy is performed if imaging is inconclusive. Biopsies help to differentiate the histological subtypes of fibrocystic changes: nonproliferative vs sclerosing adenosis vs ductal hyperplasia.
In the nonproliferative histological subtype, fluid-filled cysts are often evident. If hemorrhage has occurred inside the cyst cavity, it can appear bluish under microscopy ("blue dome cysts").
Sclerosing adenosis is a proliferative histological subtype of fibrocystic changes. Stromal fibrosis and acinar proliferation are characteristic in this subtype. If calcifications are present, the risk of breast cancer is increased.
Ductal hyperplasia is a proliferative histological subtype. The characteristic features are atypical cells with epithelial hyperplasia. This subtype also has an increased risk of breast cancer.
If symptoms are mild then treatment is usually not warranted.
If symptoms are severe, then oral contraceptive pills (OCPs), tamoxifen (SERM), or progesterone could be prescribed. These drugs inhibit the excess estrogenic activity that may be contributing to pathogenesis.
Some cases are amenable to surgical resection of cysts, especially if they case refractory pain or significant disfigurement.
Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.
*Average video play time: 2-3 minutes
Unforgettable characters with concise but impactful videos (2-4 min each)